Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Get Free Report) has been assigned an average rating of “Hold” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price objective […]
Shares of Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Get Free Report) have been given a consensus recommendation of “Hold” by the six ratings firms that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month […]
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Given Average Recommendation of "Hold" by Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) from a sell rating to a hold rating in a research report report published on Friday morning. ONCT has been the subject of a number of other research reports. Brookline Capital Management upgraded Oncternal Therapeutics from a hold rating to a buy rating and set […]
Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Get Free Report) has been given an average rating of “Hold” by the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1 […]